Dr Kari Lancaster is a Scientia Senior Research Fellow at the Centre for Social Research in Health (CSRH) at UNSW, and an Honorary Associate Professor at the London School of Hygiene and Tropical Medicine.
Kari is an interdisciplinary qualitative social researcher, with a background in law and public policy. Working at the intersection of science and technology studies (STS), policy studies, and public health sociology, Kari has made significant contributions to the critical social study of ‘evidence-based’ policy and practice in relation to viral elimination, drugs and health. Along with Professor Tim Rhodes, she leads a program of qualitative research focused on the development of critical approaches to the study of evidence-making practices, implementation science and intervention translations in health. In collaboration with clinical researchers and epidemiologists she leads qualitative research inside implementation trials and longitudinal cohort studies, including examining experiences and effects of treatment and testing technologies, especially in relation to drugs, hepatitis C, HIV and Covid-19. A defining feature of her work is using theoretically-driven approaches to inform policy and practice change.
In 2020, Kari was a recipient of the Academy of the Social Sciences in Australia Paul Bourke Award, and the Australian Political Studies Association ANZSOG Policy Studies Prize. In 2018, she received the International Society for the Study of Drug Policy Early Career Researcher Award.
Kari is an investigator on two Australian Research Council Discovery Projects 'Evidence-making and implementing interventions in a viral elimination era' (with Professor Tim Rhodes, Professor Carla Treloar, Professor Martin Holt, and Professor Marsha Rosengarten) and 'Designing illicit drug policy solutions: the role of participation' (with Professor Alison Ritter, Professor Matthew Kearnes, and Professor Jason Chilvers). She is also leading qualitative social research embedded within clinical studies in partnership with the Kirby Institute and St Vincent's Hospital Sydney, and the National Drug and Alcohol Research Centre.
Prior to joining CSRH, Kari worked as part of the Drug Policy Modelling Program (DPMP) at the National Drug and Alcohol Research Centre (NDARC), collaborating across multiple research projects investigating drug policy processes, with a particular interest in examining ‘problematisation’ and how policy problems and knowledges are constituted.
Kari is an Associate Editor of Addiction, an Associate Editor of the International Journal of Drug Policy, and a member of the editorial board of Drugs: Education, Prevention and Policy.
Kari is an elected member of the Board of the International Society for the Study of Drug Policy (ISSDP).
Research interests: drug policy, alcohol and other drugs, hepatitis C, Covid-19, viral elimination, science and technology studies (STS), qualitative methods, evidence-making practices, poststructural policy analysis, policy studies, law.
Qualifications: BA, LLB (hons), MPP, PhD